Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,161.52
(
-0.05%
)
US TECH 100
26,499.15
(
-0.21%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
101.79
(
0.25%
)
Bitcoin
77,886.32
(
-0.98%
)
News Focus
News Focus
Post# of 257447
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122892
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 142941

Thursday, 07/26/2012 9:31:03 PM

Thursday, July 26, 2012 9:31:03 PM

Post# of 257447
FDA grants priority review for Promacta in HCV:

http://finance.yahoo.com/news/ligand-partner-glaxosmithkline-announces-priority-111500097.html

Inasmuch as the NDA was submitted on 5/30/12, the PDUFA date should be on or around 11/30/12.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today